NCT02711683 DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil Status COMPLETED Phase N/A
NCT02710188 Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation Status COMPLETED Phase PHASE1
NCT02709356 Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease Status COMPLETED Phase NA
NCT02708485 Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease Status COMPLETED Phase NA
NCT02695004 Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil). Status COMPLETED Phase PHASE1
NCT02690896 Caregiver Burden and Depression: Caring for Those Who Care for Others Status COMPLETED Phase NA
NCT02686216 Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) Status COMPLETED Phase PHASE1
NCT02685969 Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants Status RECRUITING Phase N/A
NCT02672306 Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT02670993 Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease Status COMPLETED Phase NA
NCT02670083 A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Status TERMINATED Phase PHASE3
NCT02656498 [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease Status COMPLETED Phase PHASE2
NCT02654574 Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic Status COMPLETED Phase NA
NCT02649985 PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases Status RECRUITING Phase PHASE1/PHASE2
NCT02648672 BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02640092 Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Status COMPLETED Phase PHASE1